FI59251C - Foerfarande foer framstaellning av en ny 5-(4-allyl-1-piperazinyl)karbonyloxi-6-(7-klor-1,8-naftyridin-2-yl)-7-oxi-2,3-6,7-tetrahydro-5h-oxatino(1,4)(2,3-c)pyrrol anvaendbar saosom ett laekemedel - Google Patents

Foerfarande foer framstaellning av en ny 5-(4-allyl-1-piperazinyl)karbonyloxi-6-(7-klor-1,8-naftyridin-2-yl)-7-oxi-2,3-6,7-tetrahydro-5h-oxatino(1,4)(2,3-c)pyrrol anvaendbar saosom ett laekemedel Download PDF

Info

Publication number
FI59251C
FI59251C FI753126A FI753126A FI59251C FI 59251 C FI59251 C FI 59251C FI 753126 A FI753126 A FI 753126A FI 753126 A FI753126 A FI 753126A FI 59251 C FI59251 C FI 59251C
Authority
FI
Finland
Prior art keywords
chloro
naphthyridin
oxatino
tetrahydro
piperazinyl
Prior art date
Application number
FI753126A
Other languages
English (en)
Finnish (fi)
Other versions
FI753126A (ja
FI59251B (fi
Inventor
Claude Cotrel
Claude Jeanmart
Michel Barreau
Original Assignee
Rhone Poulenc Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Ind filed Critical Rhone Poulenc Ind
Publication of FI753126A publication Critical patent/FI753126A/fi
Publication of FI59251B publication Critical patent/FI59251B/fi
Application granted granted Critical
Publication of FI59251C publication Critical patent/FI59251C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
FI753126A 1974-11-07 1975-11-07 Foerfarande foer framstaellning av en ny 5-(4-allyl-1-piperazinyl)karbonyloxi-6-(7-klor-1,8-naftyridin-2-yl)-7-oxi-2,3-6,7-tetrahydro-5h-oxatino(1,4)(2,3-c)pyrrol anvaendbar saosom ett laekemedel FI59251C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7436962 1974-11-07
FR7436962A FR2290208A1 (fr) 1974-11-07 1974-11-07 Nouveaux derives de l'oxathiinno(1,4)(2,3-c)pyrrole, leur preparation et les compositions qui les contiennent

Publications (3)

Publication Number Publication Date
FI753126A FI753126A (ja) 1976-05-08
FI59251B FI59251B (fi) 1981-03-31
FI59251C true FI59251C (fi) 1981-07-10

Family

ID=9144747

Family Applications (1)

Application Number Title Priority Date Filing Date
FI753126A FI59251C (fi) 1974-11-07 1975-11-07 Foerfarande foer framstaellning av en ny 5-(4-allyl-1-piperazinyl)karbonyloxi-6-(7-klor-1,8-naftyridin-2-yl)-7-oxi-2,3-6,7-tetrahydro-5h-oxatino(1,4)(2,3-c)pyrrol anvaendbar saosom ett laekemedel

Country Status (28)

Country Link
US (1) US4021554A (ja)
JP (2) JPS6029716B2 (ja)
AR (2) AR214045A1 (ja)
AT (1) AT342603B (ja)
AU (1) AU503381B2 (ja)
BE (1) BE835324A (ja)
CA (1) CA1054599A (ja)
CH (2) CH608238A5 (ja)
CS (1) CS191285B2 (ja)
DD (1) DD122541A5 (ja)
DE (1) DE2550163C2 (ja)
DK (1) DK499175A (ja)
ES (2) ES442442A1 (ja)
FI (1) FI59251C (ja)
FR (1) FR2290208A1 (ja)
GB (1) GB1466829A (ja)
HU (1) HU170500B (ja)
IE (1) IE42030B1 (ja)
IL (1) IL48422A (ja)
LU (1) LU73737A1 (ja)
NL (1) NL7512731A (ja)
NO (1) NO143534C (ja)
OA (1) OA05141A (ja)
PH (1) PH14755A (ja)
SE (1) SE419222B (ja)
SU (2) SU576949A3 (ja)
YU (2) YU281175A (ja)
ZA (1) ZA756953B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1072557A (fr) * 1976-02-20 1980-02-26 Rhone-Poulenc Industries Derives du dithiepinno (1,4)(2,3-c) pyrrole, leur preparation et les compositions qui les contiennent
FR2525605A1 (fr) * 1982-04-22 1983-10-28 Rhone Poulenc Sante Nouveaux derives du dithiinno (1,4) (2,3-c) pyrrole, leur preparation et les medicaments qui les contiennent
FR2607504B1 (fr) * 1986-12-02 1989-01-27 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
WO2008144836A1 (en) * 2007-05-31 2008-12-04 Glycan Biosciences Sulphated xylans for treatment or prophylaxis of respiratory diseases

Also Published As

Publication number Publication date
SU576949A3 (ru) 1977-10-15
IE42030L (en) 1976-05-07
ES442441A1 (es) 1977-04-01
AU8633275A (en) 1977-05-12
ZA756953B (en) 1976-10-27
FI753126A (ja) 1976-05-08
SE7512476L (sv) 1976-05-10
AR214045A1 (es) 1979-04-30
FI59251B (fi) 1981-03-31
HU170500B (ja) 1977-06-28
BE835324A (fr) 1976-05-06
IL48422A (en) 1979-03-12
DE2550163A1 (de) 1976-05-20
JPS6029716B2 (ja) 1985-07-12
NO143534B (no) 1980-11-24
JPS60222484A (ja) 1985-11-07
US4021554A (en) 1977-05-03
DK499175A (da) 1976-05-08
CH608808A5 (ja) 1979-01-31
JPS6111954B2 (ja) 1986-04-05
JPS5170792A (en) 1976-06-18
FR2290208A1 (fr) 1976-06-04
OA05141A (fr) 1981-01-31
YU108082A (en) 1982-08-31
ATA848575A (de) 1977-08-15
DE2550163C2 (de) 1984-11-22
AU503381B2 (en) 1979-08-30
GB1466829A (en) 1977-03-09
YU281175A (en) 1982-08-31
LU73737A1 (ja) 1976-09-06
IL48422A0 (en) 1976-01-30
ES442442A1 (es) 1977-07-01
FR2290208B1 (ja) 1978-07-28
NO753712L (ja) 1976-05-10
IE42030B1 (en) 1980-05-21
DD122541A5 (ja) 1976-10-12
CA1054599A (fr) 1979-05-15
SU615860A3 (ru) 1978-07-15
PH14755A (en) 1981-11-20
NO143534C (no) 1981-03-04
CS191285B2 (en) 1979-06-29
NL7512731A (nl) 1976-05-11
CH608238A5 (ja) 1978-12-29
AR214400A1 (es) 1979-06-15
AT342603B (de) 1978-04-10
SE419222B (sv) 1981-07-20

Similar Documents

Publication Publication Date Title
US6323213B1 (en) Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives
FI79532B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,2-dihydro-2-oxo-kinolin-3-karboxamidderivat.
AU638005B2 (en) 5-alkylquinolonecarboxylic acids
NO136843B (no) Analogifremgangsm}te til fremstilling av terapeutisk aktive derivater av 5,6-dihydro-pyrrolo (3,4-b) pyrazin.
PL163626B1 (pl) Sposób wytwarzania nowych pochodnych 3-/1,2,5,6-tetrahydropirydylo/-pirolopirydyny PL PL PL
CS235502B2 (en) Method of 1-ethyl or vinyl-6-halogen-1-4-dihydro-4-oxo-7- (1-piperazinyl)-1,8-naphtyridin-3-carboxyl acid production
JPH10508613A (ja) 内部寄生虫を駆除するためのジオキソモルホリンの使用、新規ジオキソモルホリンおよびそれらの製造方法
UA43841C2 (uk) Імідазопіридини та фармацевтична композиція на їх основі
BG100459A (bg) Алкоксиалкилни карбамати от имидазо (1,2-а) пиридини
JP2023553269A (ja) イヌ糸状虫感染症を治療するためのｎ－（２，３－ジヒドロ－１，４－ベンゾオキサジン－４－イル）－３－イソプロピル－７－（２，３，５－トリフルオロフェニル）ベンゾ－チオフェン－２－カルボキサミド誘導体及び類似化合物
FI59251C (fi) Foerfarande foer framstaellning av en ny 5-(4-allyl-1-piperazinyl)karbonyloxi-6-(7-klor-1,8-naftyridin-2-yl)-7-oxi-2,3-6,7-tetrahydro-5h-oxatino(1,4)(2,3-c)pyrrol anvaendbar saosom ett laekemedel
JPS58501377A (ja) 抗炎症性置換１，２，４−トリアゾロ〔４，３−ｂ〕−１，２，４−トリアジン類
KR910000640B1 (ko) 중추 신경계에 활성을 나타내는 복소환 화합물의 제조방법
CA2673417A1 (en) Radioprotective benzimidazole compounds and related methods
US3708490A (en) Imidazothiazolium compounds,preparation and method of use
FI93963C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 3H-6H-1,4,5a,8a,-tetra-atsa-asenaftyleeni-3,5(4H)-dionijohdannaisten valmistamiseksi
KR100493576B1 (ko) 임의로치환된8-시아노-1-사이클로프로필-7-(2,8-디아자비사이클로-[4.3.0]-노난-8-일)-6-플루오로-1,4-디하이드로-4-옥소-3-퀴놀린카르복실산및그의유도체
KR910003362B1 (ko) 중추 신경계 활성을 갖는 피롤리디논의 제조방법
IE59173B1 (en) Imidazo[1,2-a]quinoline derivatives, their preparation and their application in therapy
FI61190C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 6-(piperazin-1-yl)karbonyloxi-8-oxo-3,4,7,8-tetrahydro-2h 6h-(1,4)-ditiepino(2,3-c)-pyrrolderivat
JP2641556B2 (ja) ５―（置換アミノ）―８―（フエニルまたは置換フエニル）―３Ｈ，６Ｈ―１，４，５ａ，８ａ―テトラアザアセナフチレン―３―オン
AU688462B2 (en) 8-amino-pyrido (1,2,3-d,e)(1,3,4) benzoxadiazine derivatives
TW321650B (ja)
MASUDA et al. Studies on Mesoionic Compounds. IX. Synthesis of Bicyclic Mesoionic Compounds
US5015636A (en) Thiazetidine compounds

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: RHONE- POULENC INDUSTRIES